Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 182,248,896
  • Shares Outstanding, K 538,481
  • Annual Sales, $ 33,424 M
  • Annual Income, $ 4,090 M
  • EBIT $ 8,671 M
  • EBITDA $ 14,263 M
  • 60-Month Beta 0.45
  • Price/Sales 5.21
  • Price/Cash Flow 10.66
  • Price/Book 18.12

Options Overview Details

View History
  • Implied Volatility 25.91% ( +2.87%)
  • Historical Volatility 28.74%
  • IV Percentile 44%
  • IV Rank 18.78%
  • IV High 55.92% on 11/20/24
  • IV Low 18.97% on 02/20/25
  • Put/Call Vol Ratio 0.36
  • Today's Volume 13,862
  • Volume Avg (30-Day) 9,871
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 146,149
  • Open Int (30-Day) 131,027

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 32 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.83
  • Number of Estimates 12
  • High Estimate 5.52
  • Low Estimate 4.48
  • Prior Year 5.31
  • Growth Rate Est. (year over year) -9.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
288.00 +16.76%
on 10/31/25
342.40 -1.79%
on 11/12/25
+46.15 (+15.91%)
since 10/10/25
3-Month
269.77 +24.65%
on 09/26/25
342.40 -1.79%
on 11/12/25
+51.30 (+18.00%)
since 08/12/25
52-Week
253.30 +32.76%
on 12/19/24
342.40 -1.79%
on 11/12/25
+37.44 (+12.53%)
since 11/12/24

Most Recent Stories

More News
Stocks Settle Mostly Higher on Government Reopening Optimism

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.31%. December E-mini...

AMAT : 230.73 (+0.90%)
AVGO : 355.22 (+0.93%)
MRK : 91.45 (+0.55%)
RGTI : 28.30 (-9.87%)
$IUXX : 25,517.33 (-0.06%)
AMGN : 336.28 (-0.64%)
PFE : 25.87 (+1.41%)
ELV : 327.63 (+3.93%)
ASML : 1,037.33 (+1.46%)
ZNZ25 : 112-300 (-0.06%)
CRWV : 85.43 (-3.35%)
VRTS : 165.79 (+1.15%)
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

FTRE : 11.34 (-3.82%)
PRVA : 24.22 (-0.41%)
LH : 266.00 (-0.82%)
AMGN : 336.28 (-0.64%)
ELV : 327.63 (+3.93%)
The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call

The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call

AMGN : 336.28 (-0.64%)
2 Cash-Producing Stocks to Research Further and 1 We Find Risky

2 Cash-Producing Stocks to Research Further and 1 We Find Risky

BSY : 44.38 (-1.31%)
TEAM : 155.50 (-1.29%)
AMGN : 336.28 (-0.64%)
AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL

Study Also Shows 36% Reduction in Risk of Heart Attack 

AMGN : 336.28 (-0.64%)
Amgen Stock: New All-Time Highs Ahead After Earnings Beat

Amgen stock jumps after a strong beat-and-raise quarter, pushing shares near split-adjusted all-time highs and signaling more upside ahead

AMGN : 336.28 (-0.64%)
Stocks Rise Before the Open as Bond Yields Fall on Fed Rate-Cut Bets

December S&P 500 E-Mini futures (ESZ25) are up +0.16%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.20% this morning, pointing to a higher open on Wall Street as Treasury yields fell amid growing...

ZBH : 90.03 (+1.73%)
APP : 584.86 (-1.69%)
COP : 89.07 (-1.79%)
MNST : 70.48 (-1.99%)
LR.FP : 133.650 (+1.71%)
MU : 244.90 (+1.57%)
NQZ25 : 25,648.00 (+0.09%)
ABNB : 121.69 (-0.69%)
SNAP : 9.09 (+3.77%)
AMGN : 336.28 (-0.64%)
LITE : 253.81 (+0.53%)
QCOM : 176.67 (+1.55%)
3 Large-Cap Stocks to Consider Right Now

3 Large-Cap Stocks to Consider Right Now

KLAC : 1,198.97 (+0.68%)
BX : 144.36 (-0.43%)
AMGN : 336.28 (-0.64%)
Stocks Rally on Positive US Economic News and Strength in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.72%. December E-mini...

AMAT : 230.73 (+0.90%)
ANET : 134.98 (+0.04%)
ADI : 241.44 (+3.44%)
AXON : 569.51 (-0.47%)
$IUXX : 25,517.33 (-0.06%)
LITE : 253.81 (+0.53%)
AMGN : 336.28 (-0.64%)
ZNZ25 : 112-300 (-0.06%)
ESZ25 : 6,877.00 (+0.02%)
QCOM : 176.67 (+1.55%)
GFS : 34.17 (-1.84%)
U : 40.05 (-3.38%)
Stocks Rebound on Economic Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.41%. December E-mini S&P futures (ESZ25...

AMAT : 230.73 (+0.90%)
ANET : 134.98 (+0.04%)
AVGO : 355.22 (+0.93%)
IFF : 65.41 (+0.15%)
AXON : 569.51 (-0.47%)
$IUXX : 25,517.33 (-0.06%)
LITE : 253.81 (+0.53%)
AMGN : 336.28 (-0.64%)
ZNZ25 : 112-300 (-0.06%)
ESZ25 : 6,877.00 (+0.02%)
U : 40.05 (-3.38%)
STX : 283.26 (-1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 347.10
2nd Resistance Point 344.75
1st Resistance Point 340.51
Last Price 336.28
1st Support Level 333.93
2nd Support Level 331.58
3rd Support Level 327.35

See More

52-Week High 342.40
Last Price 336.28
Fibonacci 61.8% 308.36
Fibonacci 50% 297.85
Fibonacci 38.2% 287.34
52-Week Low 253.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar